Cargando…

PB2003: REAL-WORLD DURATION OF USE AND DOSING FREQUENCY OF DARATUMUMAB IN PATIENTS WITH MULTIPLE MYELOMA IN THE U.S.

Detalles Bibliográficos
Autores principales: Fonseca, R., Chinaeke, E., Gupta, N., Fu, A., Ran, T., Kaila, S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9431399/
http://dx.doi.org/10.1097/01.HS9.0000850844.58786.ec
_version_ 1784780044867993600
author Fonseca, R.
Chinaeke, E.
Gupta, N.
Fu, A.
Ran, T.
Kaila, S.
author_facet Fonseca, R.
Chinaeke, E.
Gupta, N.
Fu, A.
Ran, T.
Kaila, S.
author_sort Fonseca, R.
collection PubMed
description
format Online
Article
Text
id pubmed-9431399
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-94313992022-08-31 PB2003: REAL-WORLD DURATION OF USE AND DOSING FREQUENCY OF DARATUMUMAB IN PATIENTS WITH MULTIPLE MYELOMA IN THE U.S. Fonseca, R. Chinaeke, E. Gupta, N. Fu, A. Ran, T. Kaila, S. Hemasphere Publication Only Lippincott Williams & Wilkins 2022-06-23 /pmc/articles/PMC9431399/ http://dx.doi.org/10.1097/01.HS9.0000850844.58786.ec Text en Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially.
spellingShingle Publication Only
Fonseca, R.
Chinaeke, E.
Gupta, N.
Fu, A.
Ran, T.
Kaila, S.
PB2003: REAL-WORLD DURATION OF USE AND DOSING FREQUENCY OF DARATUMUMAB IN PATIENTS WITH MULTIPLE MYELOMA IN THE U.S.
title PB2003: REAL-WORLD DURATION OF USE AND DOSING FREQUENCY OF DARATUMUMAB IN PATIENTS WITH MULTIPLE MYELOMA IN THE U.S.
title_full PB2003: REAL-WORLD DURATION OF USE AND DOSING FREQUENCY OF DARATUMUMAB IN PATIENTS WITH MULTIPLE MYELOMA IN THE U.S.
title_fullStr PB2003: REAL-WORLD DURATION OF USE AND DOSING FREQUENCY OF DARATUMUMAB IN PATIENTS WITH MULTIPLE MYELOMA IN THE U.S.
title_full_unstemmed PB2003: REAL-WORLD DURATION OF USE AND DOSING FREQUENCY OF DARATUMUMAB IN PATIENTS WITH MULTIPLE MYELOMA IN THE U.S.
title_short PB2003: REAL-WORLD DURATION OF USE AND DOSING FREQUENCY OF DARATUMUMAB IN PATIENTS WITH MULTIPLE MYELOMA IN THE U.S.
title_sort pb2003: real-world duration of use and dosing frequency of daratumumab in patients with multiple myeloma in the u.s.
topic Publication Only
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9431399/
http://dx.doi.org/10.1097/01.HS9.0000850844.58786.ec
work_keys_str_mv AT fonsecar pb2003realworlddurationofuseanddosingfrequencyofdaratumumabinpatientswithmultiplemyelomaintheus
AT chinaekee pb2003realworlddurationofuseanddosingfrequencyofdaratumumabinpatientswithmultiplemyelomaintheus
AT guptan pb2003realworlddurationofuseanddosingfrequencyofdaratumumabinpatientswithmultiplemyelomaintheus
AT fua pb2003realworlddurationofuseanddosingfrequencyofdaratumumabinpatientswithmultiplemyelomaintheus
AT rant pb2003realworlddurationofuseanddosingfrequencyofdaratumumabinpatientswithmultiplemyelomaintheus
AT kailas pb2003realworlddurationofuseanddosingfrequencyofdaratumumabinpatientswithmultiplemyelomaintheus